Antibiotic

Pyridomycin is a selective inhibitor of InhA, an essential enzyme in Mycobacterium tuberculosis, providing a targeted approach in combating this pathogen. As an antibiotic derived from the metabolites of Dactylosporangium fulvum, Pyridomycin exhibits low cytotoxicity while effectively impeding the growth of Mycobacterium tuberculosis. Its application is significant in the study and treatment of bacterial infections, particularly tuberculosis, making it a valuable reagent for research in infectious disease mechanisms and antibiotic development.

Saptomycin D is an antitumor antibiotic that targets various cancer cell lines and exhibits potent cytotoxicity. Isolated from the Streptomyces sp. HP530 strain, Saptomycin D demonstrates robust inhibitory effects against Gram-positive bacteria and limited activity against some Gram-negative bacteria and yeasts. This compound is particularly relevant for research applications in oncology, offering potential insights into tumor suppression mechanisms and treatment development.

Nocardicin A is a beta-lactam antibiotic targeting bacterial cell wall synthesis. It exhibits moderate antibacterial activity against a wide range of Gram-negative bacteria, including Proteus and Pseudomonas, while demonstrating no inhibitory effects on Staphylococcus, Mycobacterium, fungi, and yeast. This compound is useful in research applications focused on bacterial resistance and the mechanisms of antibiotic action.

PKUMDL-LTQ-301 is a HipA toxin inhibitor that disrupts bacterial persistence by targeting the HipA protein in Escherichia coli. This compound has demonstrated significant reduction in bacterial survival rates in both in vitro and in vivo models, making it a valuable tool for antibiotic research. PKUMDL-LTQ-301's efficacy is supported by specific KD and EC50 values, underscoring its potential in studies focused on overcoming antibiotic resistance and developing novel antibacterial therapies.

Pacidamycin I is a nucleoside peptide antibiotic that selectively targets Pseudomonas aeruginosa. It exhibits potent antibacterial activity, making it a valuable tool for research focused on combating antibiotic-resistant infections. Pacidamycin I is particularly useful in studies of microbial physiology and antibiotic development pathways.

Lavanducyanin is an antibiotic that targets microbial cell membranes, disrupting their integrity and functionality. This compound demonstrates significant antimicrobial activity, making it a valuable tool in the study of infections. Additionally, its potential as an adjuvant in cancer research presents opportunities for further exploration in therapeutic applications.

Celastramycin A is an antibiotic derived from Streptomyces MaB-QuH-8, known for its significant antimicrobial activity against a variety of gram-negative bacteria and mycobacteria, with minimum inhibitory concentrations (MICs) ranging from 0.05 to 3.1 μg/ml. This compound exhibits immunosuppressive effects, evidenced by its ability to modulate immune responses in ex vivo Drosophila and human models, demonstrating an IC50 of 0.008 μg/ml through the immune deficiency pathway and inhibiting TNF-α signaling. Additionally, Celastramycin A effectively reduces IL-8 production in human umbilical vein endothelial cells (HUEVCs), with an IC50 of 0.06 μg/ml, making it a valuable tool for research in microbial resistance and immune modulation.

Fumaramidmycin is an antibiotic derived from Streptomyces kurssanovii NR-7GG1, primarily targeting bacterial cell processes. It exhibits significant antimicrobial activity against a broad spectrum of both Gram-positive and Gram-negative bacteria. This compound is valuable for research applications focused on the mechanisms of antibiotic resistance and the development of novel antimicrobial therapies.

CK0492B is a novel biaminourea antibiotic that targets bacterial plaque formation. Demonstrating significant antiplaque properties in vitro, it has also shown efficacy in reducing dental disease symptoms in an experimental mouse model. A 12-week study conducted in beagles highlighted its effectiveness in decreasing plaque and gingivitis while assessing its safety profile. The selection of canine subjects is informed by the similarities in periodontal disease onset and progression between dogs and humans, with chlorhexidine acetate serving as a positive control for comparison.

1-Hydroxyauramycin B is an anthracycline antibiotic with a primary mechanism of action as an antitumor agent. It exhibits significant activity against Gram-positive bacteria and demonstrates effectiveness in inhibiting tumor cell proliferation. This compound is utilized in cancer research and investigations aimed at understanding its therapeutic potential in oncological applications.

Lavendofuseomycin is a macrolide pentaene antibiotic that exerts its antibacterial activity by inhibiting protein synthesis in susceptible bacteria. This compound is valuable for research applications focused on antibacterial mechanisms and the development of novel antimicrobial agents. Its unique structure and mode of action make it a significant tool for investigating antibiotic resistance and exploring therapeutic options.

Paromamine is an antibiotic that targets ribosomal RNA (rRNA) components, inhibiting bacterial protein synthesis. This compound exhibits potent antibacterial activity, making it valuable for research into bacterial resistance mechanisms and antibiotic efficacy. Its role in elucidating the interactions between antibiotics and ribosomes contributes to the development of new therapeutic strategies against infectious diseases.

Temocillin is a semisynthetic β-lactam antibiotic that functions primarily through its inhibition of bacterial cell wall synthesis. This 6-alpha-methoxy penicillin derivative exhibits a broad spectrum of activity against most aerobic Gram-negative bacteria. It is particularly valuable in research settings focused on antibiotic resistance, bacterial pathogenesis, and the development of novel therapeutic strategies against Gram-negative infections.

Pirlimycin is a lincosamide antibiotic that targets Gram-positive bacteria. Its primary mechanism involves the inhibition of bacterial protein synthesis through binding to the 50S ribosomal subunit. This action disrupts the translation process, providing effective antimicrobial activity. Pirlimycin is commonly used in research to explore antibacterial mechanisms and resistance in bacterial infections.

Flurithromycin functions as a broad-spectrum antibiotic by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. This compound exhibits significant antimicrobial activity against various gram-positive and some gram-negative bacteria. Flurithromycin is utilized in research applications focused on understanding bacterial infections and developing new therapeutic strategies.

Norfloxacin (nicotinate) is a fluoroquinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV, inhibiting their activity and preventing bacterial cell replication. This compound demonstrates significant antibacterial activity and has been utilized in veterinary medicine, particularly in animal husbandry and aquaculture. At elevated concentrations, norfloxacin nicotinate can also stimulate the innate immune response, making it a valuable tool for exploring immune modulation in research applications.

Cycloviracin B2 is an antibiotic with potent antiviral activity, primarily targeting herpes simplex virus type 1 (HSV-1). It exhibits strong inhibitory effects, making it a valuable tool for research into antiviral therapies and the mechanisms of viral infections. This compound is essential for studies focused on HSV-1 and other related viral pathogens.

Lysolipin I is a lipophilic antibiotic derived from Streptomyces violaceoniger, targeting bacterial cell membranes. It exhibits effective antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool for research in microbiology and antibiotic resistance studies. Its unique mechanism of action and broad-spectrum efficacy position it as a significant compound for exploring new therapeutic strategies against bacterial infections.

Loloatin B 10 is an antibiotic with significant antibacterial activity against gram-positive, antibiotic-resistant human pathogens. This compound targets bacterial cell viability and growth, making it a valuable tool for research applications focused on antibiotic resistance and developing new antimicrobial agents. Its efficacy against resistant strains highlights its potential in advancing therapeutic strategies in infectious disease management.

Aurein 2.3 is an antibiotic antimicrobial peptide targeting bacterial ATPases, primarily inhibiting E. coli ATPase activity. This compound demonstrates significant antibacterial activity, effectively suppressing cell growth in susceptible bacterial strains. Aurein 2.3 serves as a valuable tool in microbiological studies and the development of new antimicrobial therapies.

O-Deacetylravidomycin is an antibiotic derived from Streptomyces, functioning as a microbial metabolite. It demonstrates light-dependent antibacterial and anticancer properties, making it suitable for research applications in microbial resistance and cancer therapy studies.

Gramicidin B is a nonribosomal peptide antibiotic that exerts its action by forming ion-permeable channels in bacterial membranes. This mechanism disrupts osmotic balance, leading to cell death. Gramicidin B is widely used in research to study bacterial resistance, membrane dynamics, and the molecular mechanisms of antibiotic action. Its effectiveness against a range of Gram-positive bacteria makes it a valuable tool in microbiological investigations.

Faropenem is a potent beta-lactam antibiotic with oral bioavailability. It exhibits broad-spectrum antimicrobial activity against a variety of gram-positive and gram-negative bacteria, including both aerobes and anaerobes. Notably, Faropenem is resistant to hydrolysis by most beta-lactamases, including extended-spectrum and AmpC varieties. It has been developed as an oral proagent, faropenem medoxomil, for the investigation of respiratory tract infections and related conditions.

Respinomycin A2 is an anthracycline antibiotic known for its mechanism as an antitumor agent. It exhibits notable biological activity by inducing differentiation in leukemic K-562 cells, demonstrating potential in leukemia research and treatment. This compound may be utilized in studying the mechanisms of cancer differentiation and developing new therapeutic strategies against leukemia.

Althiomycin is a thiazole antibiotic derived from polyketide synthesis, primarily targeting Gram-positive bacteria. It exhibits potent antibacterial activity against strains such as Staphylococcus aureus, Staphylococcus epidermidis, and Streptococcus pyogenes, with minimum inhibitory concentrations (MICs) of 25 μg/mL, 25 μg/mL, and 3.1 μg/mL, respectively. Additionally, Althiomycin inhibits protein synthesis in Escherichia coli at concentrations of 1 and 10 μg/mL, though it does not affect protein synthesis in isolated rabbit reticulocytes at 100 μg/mL. This compound is useful in antibiotic research and studies related to bacterial resistance mechanisms.

4-Methylaeruginoic acid is an antitumor antibiotic that selectively targets various human tumor cell lines. This compound demonstrates significant cytotoxic activity, making it a valuable agent for cancer research. It is utilized in studies investigating mechanisms of tumor cell inhibition and potential therapeutic applications in oncology.

Ritipenem acoxil is an oral-active beta-lactamase antibiotic designed to inhibit bacterial cell wall synthesis. It demonstrates significant activity against various bacterial strains, making it a valuable tool in the study of bacterial pneumonia. This compound serves as a critical reagent for researchers investigating antibiotic resistance and the mechanisms of bacterial infections.

Chartreusin sodium is an antibiotic targeting specific Gram-positive bacteria and mycobacteria. It exhibits inhibitory activity against pathogens, including Micrococcus flavus and Staphylococcus aureus phage. This compound is valuable for research focused on antibiotic resistance and the mechanisms of bacterial infection.

Helvecardin A is a glycopeptide antibiotic that targets and disrupts cell wall synthesis in bacteria. It demonstrates potent activity against both aerobic and anaerobic Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). This compound serves as a valuable tool for research focused on antibiotic resistance and the mechanisms underlying Gram-positive bacterial infections.

Aurantiogliocladin is a weak antibiotic that primarily targets Staphylococcus epidermidis, exhibiting minimal activity against Staphylococcus aureus. This compound has shown the ability to inhibit biofilm formation, making it a valuable tool for studying bacterial adhesion and resistance mechanisms. Its selective properties may facilitate research into antibiotic efficacy and the development of strategies to combat biofilm-related infections.

Levorin A0 is an aromatic polyene antibiotic known for its potent antifungal properties. It primarily acts by disrupting the integrity of fungal cell membranes, leading to cell death. This compound is essential for research focused on antifungal drug development and understanding membrane-targeting mechanisms in fungal pathogens. Its efficacy against a range of fungi makes it a valuable tool in both in vitro and in vivo studies.

Clavicoronic acid is an inhibitor of reverse transcriptases from avian myeloblastosis virus and Moloney murine leukemia virus, exhibiting Ki values of 130 µM and 68 µM, respectively. This compound effectively inhibits the replication of vesicular stomatitis virus by disrupting its RNA-directed RNA polymerase activity. Notably, Clavicoronic acid demonstrates no cytotoxic effects, making it a valuable tool for research applications focused on viral replication mechanisms and antiviral drug development.

Aurein 1.1 is an antibiotic peptide derived from the skin of the Australian Bell Frog (Litoria raniformis). It demonstrates potent antimicrobial activity against a variety of Gram-positive and Gram-negative bacteria. This peptide is valuable for research applications in the field of antimicrobial resistance and the development of new therapeutic agents targeting bacterial infections.

Clecarmycin C is an antitumor antibiotic that exhibits significant cytotoxic properties against various tumor cell lines. Its potent antitumor activity makes it a valuable tool in cancer research. Additionally, Clecarmycin C demonstrates antimicrobial activity, providing further potential for exploration in various biological applications.

Prumycin is an antifungal antibiotic that targets Pseudoperonospora cubensis, the causative agent of cucumber powdery mildew. It effectively inhibits spore germination, demonstrating significant activity against the pathogen without triggering plant defense gene expression. This characteristic makes Prumycin a valuable tool for studying antifungal mechanisms and developing crop protection strategies in agricultural research.

Milbemycin α10 is a macrolide antibiotic that targets glutamate-gated chloride channels in nematodes and arthropods. It exhibits potent insecticidal activity, effectively controlling a variety of agricultural pests, including larvae and other harmful insects. This compound is valuable for research in agricultural biotechnology and pest management.

Saroaspidin A is an antibiotic derived from Hypericum japonicum thunb, targeting bacterial pathogens. This compound exhibits significant antibacterial activity, making it valuable for research focused on combating bacterial infections. Its unique mechanism may provide insight into novel therapeutic strategies in antibiotic development.

Binfloxacin is a fluoroquinolone antibiotic that primarily targets bacterial DNA gyrase and topoisomerase IV, thereby inhibiting bacterial DNA replication. It demonstrates effective antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Due to its minimal interference with the metabolism of theophylline, Binfloxacin is considered a safer option for combination therapies in studies involving bacterial infections and other drugs metabolized by CYP450 1A2.

Albothricin is a potent streptothricin antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. Its broad-spectrum antimicrobial activity is effective against various Gram-positive and Gram-negative bacteria, making it a valuable tool in microbial research. Albothricin is commonly utilized in studies focused on antibiotic resistance and the mechanism of action of antibacterial agents.

5′-Deoxythymidine is a thymidine analog with the 5' position substituted by hydrogen. This compound exhibits antimicrobial activity against Bacillus subtilis and Staphylococcus aureus. It serves as a valuable research tool in antiviral and anticancer studies, enabling investigations into nucleotide metabolism and cellular proliferation.

LY 186826 is a γ-lactam antibiotic that targets bacterial cell wall synthesis. This compound demonstrates potent antibacterial activity against a diverse array of both Gram-positive and Gram-negative bacteria, making it valuable for elucidating bacterial resistance mechanisms. Notably, LY 186826 is inactivated by β-lactamases and Enterobacterases, exhibiting enhanced efficacy against Enterobacter strains, which makes it an important tool in antibiotic resistance studies.

Bactobolin B (Alanylbactobolin) is a chlorine-containing antibiotic known for its antitumor properties. This compound exhibits biological activity against various bacterial strains and shows potential in cancer research. Its unique mechanism and effectiveness make it a valuable tool for investigating antibiotic resistance and cancer therapy.

Phenelfamycin F is an antibiotic that primarily targets and inhibits the growth of eutrophic bacteria. It exhibits significant antibacterial activity, making it valuable for research applications in microbiology and drug discovery. The compound can be used to study bacterial resistance mechanisms and evaluate potential therapeutic strategies against bacterial infections.

Musellactone is a lactone antibiotic derived from Musella lasiocarpa, exhibiting significant antibacterial activity against Bacillus megaterium and Sarcina lutea. This compound serves as a valuable tool for researchers investigating antimicrobial agents and exploring bacterial resistance mechanisms. Its efficacy makes it suitable for studying the pharmacological properties of natural products in the field of microbial research.

Aerocavin is an antibiotic that inhibits a broad spectrum of Gram-positive and Gram-negative bacteria, demonstrating bactericidal activity in vitro. This reagent is essential for research applications focusing on antibacterial mechanisms and the development of new antimicrobial agents. Its efficacy makes it a valuable tool for studying bacterial resistance and analyzing the pharmacodynamics of antibiotic compounds.

Quinocycline B is a quinone-containing glycoside antibiotic primarily targeting Gram-positive bacteria. Exhibiting potent antibacterial activity, it is effective against various strains that show resistance to common antibiotics. This compound is suitable for research applications in antibiotic resistance studies and the development of novel antimicrobial therapies.

Elsamicin B is an antitumor antibiotic that belongs to the Chartreusin group. It exhibits potent cytotoxic activity against a variety of cancer cell lines, making it a valuable tool for cancer research. Its mechanisms of action include DNA intercalation and disruption of topoisomerase activity, which contribute to its antitumor effects. Elsamicin B is utilized in studies focused on understanding cancer biology and the development of novel therapeutic strategies.

Plazomicin is a semi-synthetic aminoglycoside antibiotic that targets bacterial ribosomes by inhibiting protein synthesis. It serves as a substrate for aminoglycoside acetyltransferase and aminoglycoside phosphotransferase, yet remains resistant to common aminoglycoside-modifying enzymes. Plazomicin selectively inhibits MATE2-K and demonstrates significant activity against multidrug-resistant bacteria, including carbapenem-resistant Enterobacterales, making it valuable for research in antibiotic resistance and treatment efficacy studies.

Teicoplanin A2-2 is a glycopeptide antibiotic that targets bacterial cell wall synthesis. It demonstrates potent antibacterial activity, particularly against coagulase-negative staphylococci (CNS), by competitively binding to the terminal D-Ala-D-Ala peptide bonds, ultimately disrupting cell wall formation and leading to bacterial cell death. This compound is valuable for research into mechanisms of bacterial resistance and the development of novel antibiotic therapies.

Phleomycin E is an antitumor antibiotic that targets various Gram-positive bacteria, Gram-negative bacteria, and mycobacteria. It demonstrates significant antitumor activity by extending the survival time of mice bearing Ehrman’s ascites carcinoma, with an IC50 value of 0.31 μg/mL against airy entity carcinoma. This compound is valuable for research into cancer therapies and antibacterial applications.